Page last updated: 2024-10-24

telomere organization

Definition

Target type: biologicalprocess

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of telomeres, terminal regions of a linear chromosome that include the telomeric DNA repeats and associated proteins. [GOC:dph, GOC:jl, GOC:mah]

Telomere organization is a crucial biological process that ensures the stability and integrity of chromosomes. Telomeres are specialized structures located at the ends of eukaryotic chromosomes, composed of repetitive DNA sequences and associated proteins. Their primary function is to protect chromosome ends from degradation, prevent fusion with other chromosomes, and facilitate proper DNA replication.

**Telomere Formation and Maintenance:**

* **Telomere Repeat Sequences:** Telomeres are characterized by the presence of repetitive DNA sequences, typically consisting of guanine-rich repeats (e.g., TTAGGG in humans). These repeats are added to the ends of chromosomes by the enzyme telomerase, a specialized reverse transcriptase.
* **Telomerase Activity:** Telomerase uses its RNA template to extend the 3' end of the lagging strand during DNA replication. This extension compensates for the loss of DNA that occurs during each replication cycle, preventing the shortening of the chromosome.
* **Shelterin Complex:** A complex of proteins known as the shelterin complex binds to the telomeric DNA. This complex protects the telomeres from being recognized as DNA breaks and prevents their degradation by nucleases.

**Telomere Replication and Regulation:**

* **DNA Replication Problem:** The DNA polymerase enzyme cannot fully replicate the ends of linear chromosomes because it requires a primer to initiate synthesis. This leaves a gap at the 3' end of the lagging strand, leading to shortening with each replication cycle.
* **Telomerase and Replication:** Telomerase fills this gap by adding telomere repeats to the 3' end, ensuring that the chromosome remains intact.
* **Telomere Length Regulation:** Telomere length is tightly regulated. Telomerase activity is suppressed in most somatic cells, leading to progressive telomere shortening with age. This shortening contributes to cellular senescence and aging.

**Telomere Dysfunction and Disease:**

* **Telomere Shortening and Disease:** Shortened telomeres are associated with various diseases, including cancer, cardiovascular disease, and premature aging.
* **Telomerase Dysregulation:** Dysregulation of telomerase activity can lead to both cancer and premature aging. Overexpression of telomerase can contribute to tumor growth, while insufficient telomerase activity can accelerate aging.

**Telomere Organization and Function:**

* **Chromatin Structure:** Telomeres are organized into a unique chromatin structure, characterized by a specific arrangement of nucleosomes and histone modifications. This structure contributes to the stability and protection of telomeres.
* **Interaction with Nuclear Envelope:** Telomeres are often anchored to the nuclear envelope, the membrane surrounding the nucleus. This interaction helps to maintain telomere integrity and regulate their function.

**Conclusion:**

Telomere organization is a complex process that is essential for maintaining chromosomal stability and regulating cellular life span. Dysregulation of telomere function can have profound consequences for health and disease. Understanding the intricate mechanisms of telomere organization is crucial for developing therapeutic strategies to address diseases associated with telomere dysfunction.'"

Proteins (1)

ProteinDefinitionTaxonomy
Histone-lysine N-methyltransferase, H3 lysine-79 specificA histone-lysine N-methyltransferase, H3 lysine-79 specific that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8TEK3]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
toyocamycintoyocamycin : An N-glycosylpyrrolopyrimidine that is tubercidin in which the hydrogen at position 5 of the pyrrolopyrimidine moiety has been replaced by a cyano group.

Toyocamycin: 4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.
antibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
nitrile;
ribonucleoside
antimetabolite;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite
nsc 65346sangivamycin : A nucleoside analogue that is adenosine in which the nitrogen at position 7 is replaced by a carbamoyl-substituted carbon. It is a potent inhibitor of protein kinase C.

sangivamycin: RN given refers to parent cpd
nucleoside analogueprotein kinase inhibitor
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
sinefunginadenosines;
non-proteinogenic alpha-amino acid
antifungal agent;
antimicrobial agent
5-iodotubercidin7-iodotubercidin: inhibits Toxoplasma gondii adenosine kinaseorganoiodine compound
s-adenosyl-3-thiopropylamineS-adenosyl-3-thiopropylamine : A thioadenosine that is adenosine in which the hydroxy group at C-5' is replaced by a 3-aminopropyl group.

S-adenosyl-3-thiopropylamine: decarboxylated S-adenosylhomocysteine; RN given refers to parent cpd
organic sulfide;
primary amino compound;
thioadenosine
s-adenosylhomocysteineS-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine.

S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide
cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
epz004777N-glycosyl compound
epz-56765'-deoxyribonucleoside
gsk343GSK343 : A member of the class of indazoles that is 1-isopropyl-1H-indazole-4-carboxamide in which the nitrogen of the carboxamide group is substituted by a (6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl group and in which the indazole ring is substituted at position 6 by a 2-(4-methylpiperazin-1-yl)pyridin-4-yl group. A highly potent and selective EZH2 inhibitor (IC50 = 4 nM).

GSK343: an EZH2 methyltransferase inhibitor
aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
6,7-dimethoxy-2-(pyrrolidin-1-yl)-n-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine: a SETD8 inhibitor; structure in first source